Characterisation of the Novel HLA‐A*68:352 Allele by Sequencing‐Based Typing
HLA · 2026-11 · 108 (5)
DOI: 10.1111/tan.71102 ↗Kurz gefasst
Leserbrief in der Zeitschrift HLA, online erschienen am 18.11.2026. Verfasst von Lucie Blandin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Histocompatibility and Immunogenetics Laboratory, Clermont-Ferrand University Hospital, Clermont-Ferrand, France. Hauptthemen laut MEDLINE: Exons, Alleles, HLA-A Antigens, Polymorphism, Single Nucleotide. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
HLA‐A*68:352 differs from HLA‐A*68:02:01:01 by one nucleotide substitution in codon 22 in exon 2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Histocompatibility and Immunogenetics Laboratory, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.
- Clermont-Auvergne University, EA7453 CHELTER, Clermont-Ferrand, France.
- CHU de Bordeaux, Laboratoire d'Immunologie et Immunogénétique, Hôpital Pellegrin, Place Amélie Raba Léon, Bordeaux, France.
ORCID-Profile: Intissar Dalhoumi, Paul Rouzaire, Richard Lemal
Zitieren
APA
Blandin, L., Dalhoumi, I., Ralazamahaleo, M., Rouzaire, P., & Lemal, R. (2026). Characterisation of the Novel HLA‐A*68:352 Allele by Sequencing‐Based Typing. HLA, 108(5). https://doi.org/10.1111/tan.71102
Vancouver
Blandin L, Dalhoumi I, Ralazamahaleo M, Rouzaire P, Lemal R. Characterisation of the Novel HLA‐A*68:352 Allele by Sequencing‐Based Typing. HLA. 2026;108(5). doi:10.1111/tan.71102
BibTeX
@article{Blandin2026,
author = {Blandin, Lucie and Dalhoumi, Intissar and Ralazamahaleo, Mamy and Rouzaire, Paul and Lemal, Richard},
title = {Characterisation of the Novel HLA‐A*68:352 Allele by Sequencing‐Based Typing},
journal = {HLA},
year = {2026},
volume = {108},
number = {5},
doi = {10.1111/tan.71102}
}
EUVIMED